Amarin Corp Plcuk (AMRN) Gross Profit (2013 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Gross Profit of $17.8 million for Q1 2026, down 29.29% YoY from $25.1 million in Q1 2025, and down 23.31% sequentially from $23.2 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Gross Profit (2013 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Gross Profit across 14 years of filings, most recently posting $17.8 million for Q1 2026.
- In Q1 2026, Gross Profit fell 29.29% year-over-year to $17.8 million; the TTM figure through Mar 2026 stood at $113.5 million (up 52.14% YoY), while the FY2025 annual figure was $120.9 million, up 48.52% from the prior year.
- Gross Profit fell to $17.8 million in Q1 2026, from $23.2 million in the prior quarter.
- Over the last five years, Gross Profit for AMRN reached as high as $72.4 million in Q1 2022 and fell as low as -$9.6 million in Q4 2024.
- The 5-year median for Gross Profit is $42.7 million (2023), against an average of $36.9 million.
- Annual changes were most pronounced in 2024 — Gross Profit sank 121.2% — and 2025, when it surged 342.18%.
- A 5-year view of Gross Profit shows it stood at $63.6 million in 2022, then decreased by 29.05% to $45.1 million in 2023, then sank by 121.2% to -$9.6 million in 2024, then surged by 342.18% to $23.2 million in 2025, then slipped by 23.31% to $17.8 million in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $17.8 million, $23.2 million, and $22.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.77 Mn |
| Mar 31, 2026 | 17.77 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Sep 30, 2025 | 22.21 Mn |
| Sep 30, 2025 | 22.21 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Jun 30, 2025 | 50.36 Mn |
| Mar 31, 2025 | 25.13 Mn |
| Mar 31, 2025 | 25.13 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Dec 31, 2024 | -9.57 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Sep 30, 2024 | 16.28 Mn |
| Jun 30, 2024 | 42.77 Mn |
| Jun 30, 2024 | 42.77 Mn |
| Mar 31, 2024 | 31.90 Mn |
| Mar 31, 2024 | 31.90 Mn |
| Dec 31, 2023 | 45.12 Mn |
| Dec 31, 2023 | 45.12 Mn |